# A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma

> **NCT00140855** · PHASE2 · TERMINATED · sponsor: **Ludwig Institute for Cancer Research** · enrollment: 6 (actual)

## Conditions studied

- Synovial Sarcoma

## Interventions

- **BIOLOGICAL:** ipilimumab

## Key facts

- **NCT ID:** NCT00140855
- **Lead sponsor:** Ludwig Institute for Cancer Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06-08
- **Primary completion:** 2007-04-18
- **Final completion:** 2007-07-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study discontinued due to poor accrual.
- **Last updated:** 2022-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140855, "A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00140855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*